Mark Kong CFA
Stock Analyst at DBS
(2.74)
# 2,692
Out of 4,339 analysts
23
Total ratings
25%
Success rate
7.1%
Average return
Main Sectors:
Stocks Rated by Mark Kong CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1177 Sino Biopharmaceutical Limited | Initiated Coverage: Buy | $6.5 | $5.22 | +24.52% | 1 | May 20, 2026 | |
| HKG: 6160 BeOne Medicines AG | Maintained: Buy | $290 | $184.50 | +57.18% | 3 | May 7, 2026 | |
| HKG: 1681 Consun Pharmaceutical Group Limited | Maintained: Buy | $22 → $26 | $14.44 | +80.06% | 5 | Mar 27, 2026 | |
| HKG: 2105 Laekna, Inc. | Maintained: Buy | $24 | $13.17 | +83.45% | 6 | Mar 20, 2026 | |
| HKG: 1099 Sinopharm Group Co. Ltd. | Upgraded: Buy | $25 | $17.55 | n/a | 1 | Dec 12, 2024 | |
| HKG: 1515 China Resources Medical Holdings Company Limited | Maintained: Buy | $7.5 | $2.52 | n/a | 2 | Oct 24, 2024 | |
| SNY Sanofi | Maintained: Buy | n/a | $44.29 | n/a | 1 | Oct 11, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintained: Hold | n/a | $434.52 | n/a | 2 | Oct 8, 2024 | |
| ABBV AbbVie | Maintained: Hold | n/a | $215.70 | n/a | 1 | Sep 13, 2024 | |
| MRNA Moderna | Maintained: Buy | n/a | $46.88 | n/a | 1 | Sep 13, 2024 |
Sino Biopharmaceutical Limited
May 20, 2026
Initiated Coverage: Buy
Price Target: $6.5
Current: $5.22
Upside: +24.52%
BeOne Medicines AG
May 7, 2026
Maintained: Buy
Price Target: $290
Current: $184.50
Upside: +57.18%
Consun Pharmaceutical Group Limited
Mar 27, 2026
Maintained: Buy
Price Target: $22 → $26
Current: $14.44
Upside: +80.06%
Laekna, Inc.
Mar 20, 2026
Maintained: Buy
Price Target: $24
Current: $13.17
Upside: +83.45%
Sinopharm Group Co. Ltd.
Dec 12, 2024
Upgraded: Buy
Price Target: $25
Current: $17.55
Upside: n/a
China Resources Medical Holdings Company Limited
Oct 24, 2024
Maintained: Buy
Price Target: $7.5
Current: $2.52
Upside: n/a
Sanofi
Oct 11, 2024
Maintained: Buy
Price Target: n/a
Current: $44.29
Upside: n/a
Vertex Pharmaceuticals
Oct 8, 2024
Maintained: Hold
Price Target: n/a
Current: $434.52
Upside: n/a
AbbVie
Sep 13, 2024
Maintained: Hold
Price Target: n/a
Current: $215.70
Upside: n/a
Moderna
Sep 13, 2024
Maintained: Buy
Price Target: n/a
Current: $46.88
Upside: n/a